|
시장보고서
상품코드
1526402
세계의 E형 간염 진단 검사 시장 - 규모, 점유율, 동향, 산업 분석 보고서 : 검사 유형별, 최종 용도별, 지역별 시장 예측(2024-2032년)Global Hepatitis E Diagnostic Tests Market Size, Share, Trends, Industry Analysis Report: Information By Test Type, By End User, and By Region - Market Forecast, 2024 - 2032 |
||||||
Polaris Market Research의 최신 조사에 따르면 세계 E형 간염 진단 검사 시장 규모는 2032년까지 7,862만 달러에 달할 전망입니다. 이 설문조사 보고서는 현재 시장 역학을 자세히 파악하고 향후 시장 성장에 대한 분석을 제공합니다.
세계의 E형 간염 진단 검사 시장은 특히 열악한 위생 환경과 수질 오염이 만연하고 있는 개발 도상 지역에서의 E형 간염의 이환율의 상승에 의해 성장하고 있습니다. PCR 기반 분석 및 POC 검사 키트와 같은 진단 기술의 발전으로 조기 발견과 질병 관리가 향상되었습니다. 이 시장의 주요 촉진요인은 보다 효과적인 진단 솔루션이 요구되는 E형 간염의 유병률 증가와 질병 예방 및 관리에 대한 인식과 정부의 이니셔티브 증가입니다. 주목할만한 동향으로는 선진적인 분자진단제의 채용과 신흥 시장에서의 진단서비스의 확대를 들 수 있어 이용의 용이성과 저렴한 가격의 제공이 강화되고 있습니다.
경쟁 분석에서 Abbott Laboratories와 Roche는 광범위한 포트폴리오와 신흥국 시장과 선진국 시장 모두에서 강력한 존재로 눈에 띕니다.
전반적으로, E형 간염 진단 검사 시장은 기술 혁신, 접근성의 중시, 세계의 부담 증가에의 대응에 의해 특징지어져, 헬스 케어 업계 중에서도 다이나믹하고 급속하게 발전하고 있는 분야가 되고 있습니다.
E형 간염 진단 검사 시장 보고서 하이라이트
예측 기간 동안 ELISA HEV IgM 검사 부문은 시장을 독점하고 있습니다. 이러한 이점은 감염에 반응하여 생산되는 IgM 항체의 존재를 확인하기 위해 급성 E형 간염 감염의 검출에 널리 사용되고 있기 때문입니다.
RT-PCR 부문은 향후 몇 년동안 시장에서 가장 성장하는 분야입니다. 이 성장의 배경은 HEV RNA의 존재를 감지하고 감염의 조기 및 정확한 진단을 가능하게하는 고감도의 특정 진단 도구에 대한 수요 증가를 포함합니다.
병원은 광범위한 인프라, 고급 진단 장비의 가용성, 진단 서비스가 필요한 환자의 많음 등이 주된 이유입니다.
POC 부문은 시장에서 가장 높은 성장을 이루는 부문입니다. 이러한 급성장의 배경에는 편리하고 신속한 진단 솔루션에 대한 수요가 증가하고 있습니다.
북미는 시장을 독점하고 아시아태평양이 가장 높은 성장률을 보일 것으로 예상됩니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 E형 간염 진단 검사 시장 인사이트
- 용도 스냅샷
- E형 간염 진단 검사 시장 역학
- 성장 촉진요인과 기회
- 진단 기술의 진보
- 신흥 시장 진출
- 억제요인과 과제
- 고비용
- 성장 촉진요인과 기회
- PESTEL 분석
- E형 간염 진단 검사 시장의 용도 동향
- 밸류체인 분석
- COVID-19의 영향 분석
제5장 세계의 E형 간염 진단 검사 시장 : 검사 유형별
- 주요 조사 결과
- 소개
- ELISA HEV IgM 검사
- ELISA HEV IgG 검사
- 신속 진단 검사
- RT-PCR
제6장 세계의 E형 간염 진단 검사 시장 : 최종 용도별
- 주요 조사 결과
- 소개
- 병원
제7장 세계의 E형 간염 진단 검사 시장 :지역별
- 주요 조사 결과
- 소개
- E형 간염 진단 검사 시장 평가:지역별, 2019-2032년
- 북미
- 미국
- 캐나다
- 유럽
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카
- 기타 중동 및 아프리카
- 라틴아메리카
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제8장 경쟁 구도
- 확대와 인수 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제9장 기업 프로파일
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd
- Siemens Healthineers
- Bio-Rad Laboratories
- Thermo Fisher Scientific
- DiaSorin SpA
- Perkin Elmer Inc.
- QIAGEN NV
- bioMerieux SA
- Merck KGaA
- Ortho Clinical Diagnostics
- InBios International
- Altona Diagnostics
- Luminex Corporation
- Randox Laboratories
The global Hepatitis E diagnostic tests market size is expected to reach USD 78.62 million by 2032, according to a new study by Polaris Market Research. The report "Global Hepatitis E Diagnostic Tests Market Size, Share, Trends, Industry Analysis Report: By Test Type (ELISA HEV IgM Test, ELISA HEV IgG Test, Rapid Diagnostics Test, and RT-PCR), By End User (Hospitals, Diagnostic Laboratories, Research Centers, and Point-of-Care), And By Region (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) - Market Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The global Hepatitis E diagnostic tests market is experiencing growth due to the rising incidence of Hepatitis E, especially in developing regions where poor sanitation and water contamination are prevalent. Advances in diagnostic technologies, such as PCR-based assays and point-of-care testing kits, are improving early detection and disease management. Major drivers of this market are the increasing prevalence of Hepatitis E, which demands more effective diagnostic solutions, and the growing awareness and governmental efforts towards disease prevention and control. Notable trends include the adoption of advanced molecular diagnostics and the expansion of diagnostic services in emerging markets to enhance accessibility and affordability.
In terms of competitive analysis, Abbott Laboratories and Roche stand out due to their extensive portfolios and strong presence in both developed and emerging markets.
Overall, the Hepatitis E diagnostic tests market is characterized by technological innovation, a focus on accessibility, and a response to the growing global burden of the disease, making it a dynamic and rapidly evolving sector within the healthcare industry.
Hepatitis E Diagnostic Tests Market Report Highlights:
The ELISA HEV IgM test segment is dominating the market during forecast period. This dominance is attributed to its widespread use in detecting acute Hepatitis E infection, as it identifies the presence of IgM antibodies produced in response to the infection.
RT-PCR segment is the highest-growing segment within the market during upcoming years. This growth is driven by the increasing demand for highly sensitive and specific diagnostic tools that can detect the presence of HEV RNA, enabling early and accurate diagnosis of the infection.
Hospitals are the dominating segment in this market, primarily due to their extensive infrastructure, availability of advanced diagnostic equipment, and a high volume of patients requiring diagnostic services.
The Point-of-Care segment is the highest-growing segment within the market. This rapid growth is fueled by the increasing demand for convenient and quick diagnostic solutions.
North America dominates the market, while Asia-Pacific is expected to witness the highest growth rate.
Polaris Market Research has segmented the Hepatitis E diagnostics tests market report based on test type, end user, and region:
Hepatitis E Diagnostic Tests, Type Outlook (Revenue - USD Million, 2019 - 2032)
- ELISA HEV IgM Test
- ELISA HEV IgG Test
- Rapid Diagnostics Test
- RT-PCR
Hepatitis E Diagnostic Tests, End User Outlook (Revenue - USD Million, 2019 - 2032)
- Hospitals
- Diagnostic Laboratories
- Research Centers
- Point-of-Care
Hepatitis E Diagnostic Tests, Regional Outlook (Revenue - USD Million, 2019 - 2032)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia-Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Hepatitis E Diagnostic Tests Market Insights
- 4.1. Hepatitis E Diagnostic Tests Market - Application Snapshot
- 4.2. Hepatitis E Diagnostic Tests Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Advancements in Diagnostic Technologies
- 4.2.1.2. Expansion in Emerging Markets
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Costs
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Hepatitis E Diagnostic Tests Market Application Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Hepatitis E Diagnostic Tests Market, by Tests Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
- 5.3. ELISA HEV IgM Test
- 5.3.1. Global Hepatitis E Diagnostic Tests Market, by ELISA HEV IgM Test, by Region, 2019-2032 (USD Million)
- 5.4. ELISA HEV IgG Test
- 5.4.1. Global Hepatitis E Diagnostic Tests Market, by ELISA HEV IgG Test, by Region, 2019-2032 (USD Million)
- 5.5. Rapid Diagnostics Test
- 5.5.1. Global Hepatitis E Diagnostic Tests Market, by Rapid Diagnostics Test, by Region, 2019-2032 (USD Million)
- 5.6. RT-PCR
- 5.6.1. Global Hepatitis E Diagnostic Tests Market, by RT-PCR, by Region, 2019-2032 (USD Million)
6. Global Hepatitis E Diagnostic Tests Market, by End Use
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
- 6.3. Hospitals
- 6.3.1. Global Hepatitis E Diagnostic Tests Market, by Hospitals, by Region, 2019-2032 (USD Million)
- 6.3.2. Diagnostic Laboratories
- 6.3.2.1. Global Hepatitis E Diagnostic Tests Market, by Diagnostic Laboratories, by Region, 2019-2032 (USD Million)
- 6.3.3. Research Centers
- 6.3.3.1. Global Hepatitis E Diagnostic Tests Market, by Research Centers, by Region, 2019-2032 (USD Million)
- 6.3.4. Point-of-Care
- 6.3.4.1. Global Hepatitis E Diagnostic Tests Market, by Point-of-Care, by Region, 2019-2032 (USD Million)
7. Global Hepatitis E Diagnostic Tests Market, by Geography
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Hepatitis E Diagnostic Tests Market Assessment, By Geography, 2019-2032 (USD Million)
- 7.3. Hepatitis E Diagnostic Tests Market - North America
- 7.3.1. North America: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
- 7.3.2. North America: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
- 7.3.3. Hepatitis E Diagnostic Tests Market - U.S.
- 7.3.3.1. U.S.: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
- 7.3.3.2. U.S.: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
- 7.3.4. Hepatitis E Diagnostic Tests Market - Canada
- 7.3.4.1. Canada: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
- 7.3.4.2. Canada: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
- 7.4. Hepatitis E Diagnostic Tests Market - Europe
- 7.4.1. Europe: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
- 7.4.2. Europe: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
- 7.4.3. Hepatitis E Diagnostic Tests Market - UK
- 7.4.3.1. UK: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
- 7.4.3.2. UK: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
- 7.4.4. Hepatitis E Diagnostic Tests Market - France
- 7.4.4.1. France: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
- 7.4.4.2. France: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
- 7.4.5. Hepatitis E Diagnostic Tests Market - Germany
- 7.4.5.1. Germany: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
- 7.4.5.2. Germany: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
- 7.4.6. Hepatitis E Diagnostic Tests Market - Italy
- 7.4.6.1. Italy: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
- 7.4.6.2. Italy: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
- 7.4.7. Hepatitis E Diagnostic Tests Market - Spain
- 7.4.7.1. Spain: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
- 7.4.7.2. Spain: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
- 7.4.8. Hepatitis E Diagnostic Tests Market - Netherlands
- 7.4.8.1. Netherlands: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
- 7.4.8.2. Netherlands: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
- 7.4.9. Hepatitis E Diagnostic Tests Market - Russia
- 7.4.9.1. Russia: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
- 7.4.9.2. Russia: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
- 7.4.10. Hepatitis E Diagnostic Tests Market - Rest of Europe
- 7.4.10.1. Rest of Europe: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
- 7.4.10.2. Rest of Europe: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
- 7.5. Hepatitis E Diagnostic Tests Market - Asia Pacific
- 7.5.1. Asia Pacific: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
- 7.5.2. Asia Pacific: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
- 7.5.3. Hepatitis E Diagnostic Tests Market - China
- 7.5.3.1. China: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
- 7.5.3.2. China: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
- 7.5.4. Hepatitis E Diagnostic Tests Market - India
- 7.5.4.1. India: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
- 7.5.4.2. India: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
- 7.5.5. Hepatitis E Diagnostic Tests Market - Malaysia
- 7.5.5.1. Malaysia: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
- 7.5.5.2. Malaysia: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
- 7.5.6. Hepatitis E Diagnostic Tests Market - Japan
- 7.5.6.1. Japan: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
- 7.5.6.2. Japan: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
- 7.5.7. Hepatitis E Diagnostic Tests Market - Indonesia
- 7.5.7.1. Indonesia: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
- 7.5.7.2. Indonesia: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
- 7.5.8. Hepatitis E Diagnostic Tests Market - South Korea
- 7.5.8.1. South Korea: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
- 7.5.8.2. South Korea: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
- 7.5.9. Hepatitis E Diagnostic Tests Market - Australia
- 7.5.9.1. Australia: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
- 7.5.9.2. Australia: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
- 7.5.10. Hepatitis E Diagnostic Tests Market - Rest of Asia Pacific
- 7.5.10.1. Rest of Asia Pacific: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
- 7.5.10.2. Rest of Asia Pacific: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
- 7.6. Hepatitis E Diagnostic Tests Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
- 7.6.2. Middle East & Africa: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
- 7.6.3. Hepatitis E Diagnostic Tests Market - Saudi Arabia
- 7.6.3.1. Saudi Arabia: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
- 7.6.3.2. Saudi Arabia: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
- 7.6.4. Hepatitis E Diagnostic Tests Market - UAE
- 7.6.4.1. UAE: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
- 7.6.4.2. UAE: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
- 7.6.5. Hepatitis E Diagnostic Tests Market - Israel
- 7.6.5.1. Israel: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
- 7.6.5.2. Israel: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
- 7.6.6. Hepatitis E Diagnostic Tests Market - South Africa
- 7.6.6.1. South Africa: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
- 7.6.6.2. South Africa: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
- 7.6.7. Hepatitis E Diagnostic Tests Market - Rest of Middle East & Africa
- 7.6.7.1. Rest of Middle East & Africa: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
- 7.6.7.2. Rest of Middle East & Africa: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
- 7.7. Hepatitis E Diagnostic Tests Market - Latin America
- 7.7.1. Latin America: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
- 7.7.2. Latin America: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
- 7.7.3. Hepatitis E Diagnostic Tests Market - Mexico
- 7.7.3.1. Mexico: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
- 7.7.3.2. Mexico: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
- 7.7.4. Hepatitis E Diagnostic Tests Market - Brazil
- 7.7.4.1. Brazil: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
- 7.7.4.2. Brazil: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
- 7.7.5. Hepatitis E Diagnostic Tests Market - Argentina
- 7.7.5.1. Argentina: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
- 7.7.5.2. Argentina: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
- 7.7.6. Hepatitis E Diagnostic Tests Market - Rest of Latin America
- 7.7.6.1. Rest of Latin America: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
- 7.7.6.2. Rest of Latin America: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
- 9.1. Abbott Laboratories
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. F. Hoffmann-La Roche Ltd
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. Siemens Healthineers
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. Bio-Rad Laboratories
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. Thermo Fisher Scientific
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. DiaSorin S.p.A.
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. Perkin Elmer Inc.
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. QIAGEN N.V.
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. bioMerieux SA
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. Merck KGaA
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
- 9.11. Ortho Clinical Diagnostics
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development
- 9.12. InBios International
- 9.12.1. Company Overview
- 9.12.2. Financial Performance
- 9.12.3. Product Benchmarking
- 9.12.4. Recent Development
- 9.13. Altona Diagnostics
- 9.13.1. Company Overview
- 9.13.2. Financial Performance
- 9.13.3. Product Benchmarking
- 9.13.4. Recent Development
- 9.14. Luminex Corporation
- 9.14.1. Company Overview
- 9.14.2. Financial Performance
- 9.14.3. Product Benchmarking
- 9.14.4. Recent Development
- 9.15. Randox Laboratories
- 9.15.1. Company Overview
- 9.15.2. Financial Performance
- 9.15.3. Product Benchmarking
- 9.15.4. Recent Development
